Study: 38% of FDA Advisory Meetings Included a Patient or Consumer Rep Tied to a Pharma-Funded Group

Patient and consumer representatives are supposed to bring the public's voice into FDA drug reviews. A new USC analysis finds that in more than 1 in 10 advisory meetings, one of them was affiliated with a group funded by the very company whose drug was on the table.